Background: Chronic lymphocytic leukemia (CLL) has a heterogeneous clinical course. Beside patients requiring immediate treatment, others show an initial indolent phase followed by progression and others do not progress for decades. The latter two subgroups usually display mutated IGHV genes and a favorable FISH profile. Patients and methods: Patients with absence of disease progression for over 10 years (10-34) from diagnosis were defined as ultra-stable CLL (US-CLL). Forty US-CLL underwent extensive characterization including whole exome sequencing (WES), ultradeep sequencing and copy number aberration (CNA) analysis to define their unexplored genetic landscape. Microarray analysis, comparing US-CLL with non-US-CLL with similar immunogene...
The identification of new genetic lesions in chronic lymphocytic leukemia (CLL) prompts a comprehens...
Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world and shows a rema...
The identification of new genetic lesions in chronic lymphocytic leukemia (CLL) prompts a comprehens...
BACKGROUND: Chronic lymphocytic leukemia (CLL) has a heterogeneous clinical course. Beside patients...
Chronic lymphocytic leukemia (CLL) has a heterogeneous clinical course. Beside patients requiring im...
Chronic lymphocytic leukemia (CLL) has a heterogeneous clinical course. Beside patients requiring im...
Chronic lymphocytic leukaemia (CLL) is characterised by a chronically relapsing course and clinical ...
Chronic lymphocytic leukaemia (CLL) is a molecularly heterogeneous disease as revealed by recent gen...
Chronic lymphocytic leukaemia (CLL) is a molecularly heterogeneous disease as revealed by recent gen...
A genomic, transcriptomic and epigenomic analysis of chronic lymphocytic leukemia identifies genetic...
A genomic, transcriptomic and epigenomic analysis of chronic lymphocytic leukemia identifies genetic...
Chronic lymphocytic leukaemia (CLL) remains at the forefront of the genetic analysis of human tumour...
Genomic analyses of chronic lymphocytic leukemia (CLL) identified somatic mutations and associations...
Recent advances in cancer characterization have consistently revealed marked heterogeneity, impeding...
Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world and shows a rema...
The identification of new genetic lesions in chronic lymphocytic leukemia (CLL) prompts a comprehens...
Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world and shows a rema...
The identification of new genetic lesions in chronic lymphocytic leukemia (CLL) prompts a comprehens...
BACKGROUND: Chronic lymphocytic leukemia (CLL) has a heterogeneous clinical course. Beside patients...
Chronic lymphocytic leukemia (CLL) has a heterogeneous clinical course. Beside patients requiring im...
Chronic lymphocytic leukemia (CLL) has a heterogeneous clinical course. Beside patients requiring im...
Chronic lymphocytic leukaemia (CLL) is characterised by a chronically relapsing course and clinical ...
Chronic lymphocytic leukaemia (CLL) is a molecularly heterogeneous disease as revealed by recent gen...
Chronic lymphocytic leukaemia (CLL) is a molecularly heterogeneous disease as revealed by recent gen...
A genomic, transcriptomic and epigenomic analysis of chronic lymphocytic leukemia identifies genetic...
A genomic, transcriptomic and epigenomic analysis of chronic lymphocytic leukemia identifies genetic...
Chronic lymphocytic leukaemia (CLL) remains at the forefront of the genetic analysis of human tumour...
Genomic analyses of chronic lymphocytic leukemia (CLL) identified somatic mutations and associations...
Recent advances in cancer characterization have consistently revealed marked heterogeneity, impeding...
Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world and shows a rema...
The identification of new genetic lesions in chronic lymphocytic leukemia (CLL) prompts a comprehens...
Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world and shows a rema...
The identification of new genetic lesions in chronic lymphocytic leukemia (CLL) prompts a comprehens...